marketcaparena
Search

    UTMD

    UTAH MEDICAL PRODUCTS INC

    Company overview

    Market capitalization
    $237.16M
    Employees
    140
    Latest publication
    2026-09-29
    About UTAH MEDICAL PRODUCTS INC

    Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue8,529,000USD8,722,000USD9,044,000USD9,812,000USD9,953,000USD9,710,000USD9,158,000USD10,005,000USD
    Cost Of Revenue3,771,000USD3,440,000USD4,313,000USD4,752,000USD4,897,000USD4,172,000USD3,835,000USD4,728,000USD
    Gross Profit4,758,000USD5,282,000USD4,731,000USD5,060,000USD5,056,000USD5,538,000USD5,323,000USD5,277,000USD
    Research Development154,000USD154,000USD212,000USD167,000USD135,000USD155,000USD121,000USD172,000USD
    Selling General Administrative1,955,000USD1,664,000USD2,611,000USD2,826,000USD2,264,000USD915,000USD5,696,000USD739,000USD
    Total Operating Expenses2,109,000USD2,717,000USD2,289,000USD2,449,000USD1,860,000USD2,385,000USD2,393,000USD1,934,000USD
    Operating Income2,649,000USD2,565,000USD2,442,000USD2,611,000USD3,196,000USD3,153,000USD2,930,000USD3,343,000USD
    Total Other Income Expense Net637,000USD617,000USD664,000USD698,000USD639,000USD705,000USD684,000USD836,000USD
    Income Before Tax3,286,000USD3,182,000USD3,106,000USD3,309,000USD3,835,000USD3,858,000USD3,614,000USD4,179,000USD
    Income Tax Expense600,000USD578,000USD541,000USD678,000USD787,000USD817,000USD712,000USD616,000USD
    Net Income2,686,000USD2,604,000USD2,565,000USD2,631,000USD3,048,000USD3,041,000USD2,902,000USD3,563,000USD
    Tax Provision—578,000USD540,000USD678,000USD788,000USD817,000USD712,000USD616,000USD
    Net Income From Continuing Ops—2,604,000USD2,566,000USD2,631,000USD3,048,000USD3,041,000USD2,902,000USD3,563,000USD
    Ebit—3,182,000USD3,106,000USD3,309,000USD3,836,000USD3,467,000USD3,267,000USD4,179,000USD
    Ebitda—3,870,000USD3,851,000USD4,062,000USD4,581,000USD4,188,000USD3,984,000USD4,919,000USD
    Depreciation And Amortization—688,000USD745,000USD753,000USD745,000USD721,000USD717,000USD740,000USD
    Reconciled Depreciation—688,000USD760,000USD769,000USD758,000USD721,000USD730,000USD740,000USD
    Selling And Marketing Expenses—————500,000USD—438,000USD
    Unclassified Operating Expenses——————-3,424,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue38,520,000USD40,903,000USD50,224,000USD52,281,000USD49,054,000USD42,178,000USD46,904,000USD41,998,000USD
    Cost Of Revenue18,645,000USD16,760,000USD20,186,000USD20,085,000USD18,137,000USD16,630,000USD17,438,000USD15,692,000USD
    Gross Profit19,875,000USD24,143,000USD30,038,000USD32,196,000USD30,917,000USD25,548,000USD29,466,000USD26,306,000USD
    Research Development668,000USD813,000USD560,000USD493,000USD526,000USD486,000USD483,000USD454,000USD
    Selling General Administrative9,931,000USD3,666,000USD11,016,000USD10,406,000USD10,097,000USD9,800,000USD9,613,000USD5,447,000USD
    Unclassified Operating Expenses-2,126,000USD4,169,000USD——————
    Total Operating Expenses8,473,000USD10,549,000USD13,261,000USD12,406,000USD12,037,000USD11,840,000USD11,834,000USD7,609,000USD
    Operating Income11,402,000USD13,594,000USD16,777,000USD19,790,000USD18,880,000USD13,708,000USD17,632,000USD18,697,000USD
    Income Before Tax14,110,000USD16,802,000USD20,089,000USD20,659,000USD19,061,000USD13,840,000USD17,884,000USD19,458,000USD
    Income Tax Expense2,824,000USD2,928,000USD3,454,000USD4,186,000USD4,273,000USD3,042,000USD3,157,000USD904,000USD
    Tax Provision2,824,000USD2,928,000USD3,759,000USD4,186,000USD4,273,000USD3,042,000USD3,157,000USD904,000USD
    Net Income11,286,000USD13,874,000USD16,635,000USD16,473,000USD14,788,000USD10,798,000USD14,727,000USD18,554,000USD
    Net Income From Continuing Ops11,286,000USD13,874,000USD16,904,000USD20,659,000USD19,061,000USD13,840,000USD14,727,000USD18,555,000USD
    Ebit14,110,000USD16,802,000USD18,384,000USD20,659,000USD19,061,000USD13,708,000USD17,632,000USD18,697,000USD
    Ebitda17,062,000USD19,572,666USD24,752,000USD27,741,000USD26,345,000USD20,917,000USD24,514,000USD21,653,000USD
    Depreciation And Amortization2,952,000USD2,770,666USD6,368,000USD7,082,000USD7,284,000USD7,209,000USD6,882,000USD2,956,000USD
    Reconciled Depreciation3,008,000USD2,846,000USD7,080,000USD7,082,000USD7,284,000USD7,209,000USD6,882,000USD2,956,000USD
    Total Other Income Expense Net2,708,000USD3,208,000USD3,312,000USD869,000USD181,000USD132,000USD252,000USD762,000USD
    Selling And Marketing Expenses—1,901,000USD1,685,000USD1,507,000USD1,414,000USD1,554,000USD1,738,000USD1,708,000USD
    Interest Expense———869,000USD4,182,000USD7,341,000USD7,133,000USD0USD
    Non Operating Income Net Other———208,000USD15,000USD20,000USD-2,000USD545,000USD
    Net Income Applicable To Common Shares———16,473,000USD14,788,000USD10,798,000USD14,727,000USD18,555,000USD
    Interest Income——————254,000USD249,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets124,572,000USD124,382,000USD122,542,000USD121,975,000USD120,802,000USD122,519,000USD122,538,000USD129,694,000USD
    Cash And Equivalents87,528,000USD———————
    Total Current Assets100,639,000USD100,378,000USD97,742,000USD96,532,000USD94,375,000USD96,399,000USD96,330,000USD101,656,000USD
    Other Current Assets543,000USD614,000USD529,000USD422,000USD331,000USD482,000USD448,000USD377,000USD
    Total Liabilities2,539,000USD———————
    Total Current Liabilities2,070,000USD3,505,000USD2,598,000USD3,011,000USD2,254,000USD4,324,000USD3,757,000USD3,435,000USD
    Other Current Liabilities1,194,000USD———————
    Total Stockholder Equity122,033,000USD120,373,000USD119,268,000USD118,252,000USD117,533,000USD117,047,000USD117,427,000USD124,197,000USD
    Total Equity Including Noncontrolling Interest122,034,000USD———————
    Long Term Debt195,000USD———————
    Net Receivables3,565,000USD3,636,000USD3,522,000USD3,725,000USD3,632,000USD3,944,000USD4,094,000USD3,720,000USD
    Inventory9,003,000USD8,722,000USD7,935,000USD8,118,000USD8,233,000USD8,648,000USD8,812,000USD9,107,000USD
    Property Plant Equipment Net9,631,000USD9,721,000USD9,908,000USD10,000,000USD10,257,000USD9,945,000USD9,763,000USD10,419,000USD
    Goodwill13,956,000USD———————
    Intangible Assets346,000USD363,999USD840,000USD1,392,000USD1,977,000USD2,405,000USD2,865,000USD3,592,000USD
    Accounts Payable876,000USD1,194,000USD911,000USD768,000USD737,000USD914,000USD696,000USD999,000USD
    Common Stock32,000USD32,000USD32,000USD32,000USD32,000USD33,000USD33,000USD34,000USD
    Retained Earnings131,954,000USD130,259,999USD128,651,999USD127,958,000USD126,863,000USD128,204,000USD129,302,000USD134,053,000USD
    Total Liab—4,009,000USD3,274,000USD3,723,000USD3,269,000USD5,472,000USD5,111,000USD5,497,000USD
    Other Current Liab—2,311,000USD1,687,000USD2,243,000USD1,517,000USD3,410,000USD3,214,000USD2,436,000USD
    Capital Stock—32,000USD32,000USD32,000USD32,000USD33,000USD33,000USD34,000USD
    Good Will—13,919,000USD14,052,000USD14,051,000USD14,193,000USD13,770,000USD13,580,000USD14,027,000USD
    Cash—87,406,000USD85,756,000USD84,267,000USD82,179,000USD83,325,000USD82,976,000USD88,452,000USD
    Cash And Short Term Investments—87,406,000USD85,756,000USD84,267,000USD82,179,000USD83,325,000USD82,976,000USD88,452,000USD
    Net Debt—-87,196,000USD-85,531,000USD-84,026,000USD-81,923,000USD-83,056,000USD-82,694,000USD-88,153,000USD
    Short Long Term Debt Total—210,000USD225,000USD241,000USD256,000USD269,000USD282,000USD299,000USD
    Accumulated Other Comprehensive Income—-9,919,000USD-9,416,000USD-9,738,000USD-9,362,000USD-11,190,000USD-11,908,000USD-9,890,000USD
    Common Stock Shares Outstanding—3,185,000shares3,198,000shares3,207,000shares3,245,979shares3,310,000shares3,388,000shares3,478,000shares
    Non Current Assets Total—24,004,000USD24,799,999USD25,442,999USD26,427,000USD26,120,000USD26,208,000USD28,038,000USD
    Non Current Liabilities Total—504,000USD676,000USD711,999USD1,015,000USD1,148,000USD1,354,000USD2,062,000USD
    Net Working Capital—96,873,000USD95,144,000USD93,521,000USD92,121,000USD92,075,000USD92,573,000USD98,221,000USD
    Property Plant Equipment Gross——35,247,000USD———33,689,000USD10,419,000USD
    Unclassified Non Current Liabilities————1,015,000USD1,148,000USD1,354,000USD1,364,000USD
    Short Term Debt——————56,000USD—
    Other Assets———————1USD
    Non Current Liabilities Other———————698,000USD
    Non Currrent Assets Other———————-1USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets122,542,000USD122,538,000USD135,458,000USD123,874,000USD115,636,000USD111,745,000USD109,787,000USD99,768,000USD
    Intangible Assets840,000USD2,865,000USD4,946,000USD10,377,000USD17,762,000USD23,993,000USD30,212,000USD14,803,000USD
    Other Current Assets529,000USD448,999USD429,000USD515,000USD457,000USD346,000USD443,000USD436,000USD
    Total Liab3,274,000USD5,111,000USD7,145,000USD9,620,000USD8,498,000USD8,923,000USD8,695,000USD10,776,000USD
    Total Stockholder Equity119,268,000USD117,427,000USD128,313,000USD114,254,000USD107,138,000USD102,822,000USD101,092,000USD88,992,000USD
    Other Current Liab1,687,000USD3,158,000USD3,614,000USD4,405,000USD2,948,000USD2,924,000USD2,287,000USD2,341,000USD
    Common Stock32,000USD33,000USD36,000USD36,000USD37,000USD36,000USD37,000USD37,000USD
    Capital Stock32,000USD33,000USD36,000USD36,000USD37,000USD36,000USD37,000USD37,000USD
    Retained Earnings128,651,999USD129,302,000USD138,341,000USD126,006,000USD115,314,000USD110,952,000USD110,820,000USD100,123,000USD
    Good Will14,052,000USD13,580,000USD13,692,000USD13,354,000USD14,098,000USD14,164,000USD13,961,000USD13,703,000USD
    Cash85,756,000USD82,976,000USD92,868,000USD75,052,000USD60,974,000USD51,590,000USD42,787,000USD51,112,000USD
    Cash And Short Term Investments85,756,000USD82,976,000USD92,868,000USD75,052,000USD60,974,000USD51,590,000USD42,787,000USD51,112,000USD
    Total Current Assets97,742,000USD96,331,000USD106,269,000USD89,919,000USD73,158,000USD62,262,000USD54,885,000USD60,903,000USD
    Total Current Liabilities2,598,000USD3,757,000USD4,710,000USD5,960,000USD3,745,000USD3,791,000USD3,448,000USD5,260,000USD
    Net Debt-85,531,000USD-82,694,000USD-92,573,000USD-74,711,000USD-60,578,000USD-51,255,000USD-42,411,000USD-51,112,000USD
    Short Long Term Debt Total225,000USD338,000USD295,000USD341,000USD396,000USD335,000USD376,000USD—
    Net Receivables3,522,000USD4,094,000USD3,390,000USD5,538,000USD5,131,000USD4,104,000USD4,742,000USD3,956,000USD
    Inventory7,935,000USD8,812,000USD9,582,000USD8,814,000USD6,596,000USD6,222,000USD6,913,000USD5,413,000USD
    Accounts Payable911,000USD543,000USD769,000USD1,218,000USD761,000USD788,000USD1,098,000USD975,000USD
    Property Plant Equipment Net9,908,000USD9,762,000USD10,551,000USD10,224,000USD10,618,000USD11,326,000USD10,729,000USD10,359,000USD
    Property Plant Equipment Gross35,247,000USD33,689,000USD34,273,000USD33,168,000USD33,869,000USD11,326,000USD10,728,000USD10,359,000USD
    Accumulated Other Comprehensive Income-9,416,000USD-11,908,000USD-10,658,000USD-12,039,000USD-9,054,000USD-8,281,000USD-9,782,000USD-11,290,000USD
    Common Stock Shares Outstanding3,240,000shares3,503,000shares3,637,000shares3,643,000shares3,660,000shares3,672,000shares3,739,000shares3,748,000shares
    Non Current Assets Total24,799,999USD26,207,000USD29,189,000USD33,955,000USD42,478,000USD49,483,000USD54,902,000USD38,865,000USD
    Non Current Liabilities Total676,000USD1,354,000USD2,435,000USD3,660,000USD4,753,000USD5,132,000USD5,247,000USD5,516,000USD
    Net Working Capital95,144,000USD92,573,000USD101,559,000USD84,166,000USD69,558,000USD58,471,000USD51,438,000USD55,643,000USD
    Short Term Debt—56,000USD47,000USD54,000USD52,000USD41,000USD38,000USD—
    Unclassified Non Current Liabilities—1,354,000USD2,435,000USD-3,319,000USD-4,492,000USD-4,797,000USD-4,869,000USD-5,516,000USD
    Other Assets——1USD—-1,000USD———
    Current Deferred Revenue——327,000USD-54,000USD-52,000USD-41,000USD-38,000USD—
    Short Term Investments——185,738,000USD————0USD
    Non Currrent Assets Other——-1USD-1,909,000USD-2,104,000USD-49,483,000USD54,901,000USD38,865,000USD
    Unclassified Current Assets——-185,738,000USD—————
    Deferred Long Term Liab———549,000USD577,000USD651,000USD521,000USD535,000USD
    Other Liab———3,319,000USD4,492,000USD4,797,000USD4,870,000USD5,516,000USD
    Non Current Liabilities Other———3,111,000USD4,176,000USD4,481,000USD4,725,000USD4,981,000USD
    Net Tangible Assets———90,523,000USD75,726,000USD64,665,000USD56,920,000USD60,486,000USD
    Unclassified Non Current Assets——————-54,901,000USD-38,865,000USD
    Unclassified Current Liabilities———————1,944,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income2,604,000USD2,565,000USD2,631,000USD3,048,000USD3,041,000USD2,902,000USD3,563,000USD3,453,000USD
    Depreciation688,000USD760,000USD769,000USD758,000USD721,000USD730,000USD740,000USD693,000USD
    Stock Based Compensation120,000USD111,000USD94,000USD86,000USD82,000USD72,000USD53,000USD52,000USD
    Other Non Cash Items-5,000USD715,000USD402,000USD2,000USD-9,000USD2,000USD1,548,000USD2,000USD
    Change To Account Receivables-130,000USD430,000USD-506,000USD397,000USD12,000USD-475,000USD-9,000USD-83,000USD
    Change To Inventory-830,000USD186,000USD101,000USD633,000USD275,000USD79,000USD67,000USD170,000USD
    Change In Working Capital-141,000USD86,000USD263,000USD-870,000USD838,000USD-828,000USD-447,000USD-1,277,000USD
    Total Cash From Operating Activities3,109,000USD3,477,000USD3,878,000USD2,873,000USD4,464,000USD2,937,000USD3,856,000USD2,762,000USD
    Capital Expenditures-130,000USD-109,000USD-27,000USD-51,000USD-184,000USD-9,000USD-137,000USD-115,000USD
    Free Cash Flow2,979,000USD3,368,000USD3,851,000USD2,822,000USD4,280,000USD2,928,000USD3,993,000USD2,647,000USD
    Total Cashflows From Investing Activities-130,000USD-109,000USD-27,000USD-51,000USD-184,000USD-9,000USD-89,000USD-115,000USD
    Total Cash From Financing Activities-1,117,000USD-1,971,000USD-1,641,000USD-4,488,000USD-4,238,000USD-7,747,000USD-4,918,000USD-7,190,000USD
    Dividends Paid-989,000USD-977,000USD-988,000USD-1,001,000USD-1,017,000USD-1,038,000USD-1,052,000USD-1,081,000USD
    Sale Purchase Of Stock-128,000USD-994,000USD-653,000USD-3,487,000USD-3,221,000USD-6,709,000USD-3,866,000USD-6,403,000USD
    Change In Cash1,650,000USD1,489,000USD2,088,000USD-1,146,000USD349,000USD-5,476,000USD-767,000USD-4,589,000USD
    Begin Period Cash Flow85,756,000USD84,267,000USD82,179,000USD83,325,000USD82,976,000USD88,452,000USD89,219,000USD93,808,000USD
    End Period Cash Flow87,406,000USD85,756,000USD84,267,000USD82,179,000USD83,325,000USD82,976,000USD88,452,000USD89,219,000USD
    Other Cashflows From Investing Activities—310,000USD————-226,000USD-5,000USD
    Other Cashflows From Financing Activities—13,373,000USD————-89,000USD294,000USD
    Unclassified Financing Cash Flow—-13,373,000USD——————
    Investments——-27,000USD-51,000USD-184,000USD-9,000USD-89,000USD-115,000USD
    Unclassified Operating Cash Flow——————-1,601,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income11,286,000USD13,874,000USD16,635,000USD16,473,000USD14,788,000USD10,798,000USD14,727,000USD18,555,000USD
    Depreciation3,008,000USD2,846,000USD6,368,000USD7,082,000USD7,284,000USD7,209,000USD6,882,000USD2,956,000USD
    Stock Based Compensation373,000USD256,000USD225,000USD183,000USD166,000USD160,000USD113,000USD64,000USD
    Other Non Cash Items367,000USD-4,000USD-33,000USD36,000USD63,000USD3,000USD53,000USD-373,000USD
    Change To Account Receivables333,000USD-781,000USD2,270,000USD-511,000USD-1,088,000USD617,000USD-738,000USD-496,000USD
    Change To Inventory1,195,000USD587,000USD-670,000USD-2,353,000USD-485,000USD924,000USD-1,686,000USD-244,000USD
    Change In Working Capital317,000USD-1,803,000USD-233,000USD-2,226,000USD-1,006,000USD1,993,000USD-4,323,000USD-4,042,000USD
    Total Cash From Operating Activities14,692,000USD14,831,000USD22,281,000USD21,147,000USD21,203,000USD20,137,000USD17,056,000USD16,834,000USD
    Capital Expenditures-371,000USD-235,000USD-639,000USD-818,000USD-552,000USD-860,000USD-21,540,000USD-402,000USD
    Free Cash Flow14,321,000USD14,596,000USD21,642,000USD20,329,000USD20,651,000USD19,277,000USD-4,484,000USD16,432,000USD
    Total Cashflows From Investing Activities-371,000USD-208,000USD-639,000USD-818,000USD-552,000USD-860,000USD-21,540,000USD534,000USD
    Total Cash From Financing Activities-12,338,000USD-23,838,000USD-4,165,000USD-5,484,000USD-10,905,000USD-10,734,000USD-4,227,000USD-4,777,000USD
    Dividends Paid-3,983,000USD-4,260,000USD-4,282,000USD-3,163,000USD-11,465,000USD-4,116,000USD-4,112,000USD-4,026,000USD
    Sale Purchase Of Stock-8,355,000USD-19,968,000USD-2,495,000USD-2,495,000USD-6,976,000USD-6,976,000USD-398,000USD-1,205,000USD
    Change In Cash2,780,000USD-9,892,000USD17,816,000USD14,078,000USD9,384,000USD8,803,000USD-8,325,000USD11,237,000USD
    Begin Period Cash Flow82,976,000USD92,868,000USD75,052,000USD60,974,000USD51,590,000USD42,787,000USD51,112,000USD39,875,000USD
    End Period Cash Flow85,756,000USD82,976,000USD92,868,000USD75,052,000USD60,974,000USD51,590,000USD42,787,000USD51,112,000USD
    Investments—-208,000USD-587,000USD-818,000USD-552,000USD-860,000USD-21,540,000USD74,000USD
    Other Cashflows From Investing Activities—27,000USD—-9,000USD-860,000USD-21,540,000USD-21,000,000USD862,000USD
    Other Cashflows From Financing Activities—390,000USD117,000USD-818,000USD13,796,000USD358,000USD283,000USD454,000USD
    Unclassified Financing Cash Flow——2,495,000USD—-6,260,000USD———
    Change To Liabilities———716,000USD690,000USD-308,000USD-1,537,000USD-506,000USD
    Cash And Cash Equivalents Changes———14,845,000USD9,384,000USD8,803,000USD-8,325,000USD11,237,000USD
    Exchange Rate Changes————-362,000USD260,000USD386,000USD-1,354,000USD
    Unclassified Investing Cash Flow————1,412,000USD22,400,000USD42,540,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyDomestic Us5,560,000USD0001096906-26-000767
    Q1 2026Quarterly · 2026-03-31GeographyOutside Us3,162,000USD0001096906-26-000767
    Q1 2026Quarterly · 2026-03-31ProductBlood Pressure Monitoring And Accessories1,019,000USD0001096906-26-000767
    Q1 2026Quarterly · 2026-03-31ProductGynecology Electrosurgery Urology5,228,000USD0001096906-26-000767
    Q1 2026Quarterly · 2026-03-31ProductNeonatal1,570,000USD0001096906-26-000767
    Q1 2026Quarterly · 2026-03-31ProductObstetrics905,000USD0001096906-26-000767
    Q3 2025Quarterly · 2025-09-30GeographyDomestic Us5,859,000USD0001096906-25-001839
    Q3 2025Quarterly · 2025-09-30GeographyOutside Us3,953,000USD0001096906-25-001839
    Q3 2025Quarterly · 2025-09-30ProductBlood Pressure Monitoring And Accessories1,643,000USD0001096906-25-001839
    Q3 2025Quarterly · 2025-09-30ProductGynecology Electrosurgery Urology4,954,000USD0001096906-25-001839
    Q3 2025Quarterly · 2025-09-30ProductNeonatal2,176,000USD0001096906-25-001839
    Q3 2025Quarterly · 2025-09-30ProductObstetrics1,039,000USD0001096906-25-001839
    Q2 2025Quarterly · 2025-06-30GeographyDomestic Us5,865,000USD0001096906-25-001281
    Q2 2025Quarterly · 2025-06-30GeographyOutside Us4,088,000USD0001096906-25-001281
    Q2 2025Quarterly · 2025-06-30ProductBlood Pressure Monitoring And Accessories2,019,000USD0001096906-25-001281
    Q2 2025Quarterly · 2025-06-30ProductGynecology Electrosurgery Urology4,807,000USD0001096906-25-001281
    Q2 2025Quarterly · 2025-06-30ProductNeonatal2,102,000USD0001096906-25-001281
    Q2 2025Quarterly · 2025-06-30ProductObstetrics1,025,000USD0001096906-25-001281
    Q1 2025Quarterly · 2025-03-31GeographyDomestic Us5,583,000USD0001096906-25-000816
    Q1 2025Quarterly · 2025-03-31GeographyOutside Us4,127,000USD0001096906-25-000816
    Q1 2025Quarterly · 2025-03-31ProductBlood Pressure Monitoring And Accessories1,807,000USD0001096906-25-000816
    Q1 2025Quarterly · 2025-03-31ProductGynecology Electrosurgery Urology4,896,000USD0001096906-25-000816
    Q1 2025Quarterly · 2025-03-31ProductNeonatal1,982,000USD0001096906-25-000816
    Q1 2025Quarterly · 2025-03-31ProductObstetrics1,025,000USD0001096906-25-000816
    Q3 2024Quarterly · 2024-09-30GeographyDomestic Us5,687,000USD0001811884-24-000022
    Q3 2024Quarterly · 2024-09-30GeographyOutside Us4,318,000USD0001811884-24-000022
    Q3 2024Quarterly · 2024-09-30ProductBlood Pressure Monitoring And Accessories2,146,000USD0001811884-24-000022
    Q3 2024Quarterly · 2024-09-30ProductGynecology Electrosurgery Urology5,093,000USD0001811884-24-000022
    Q3 2024Quarterly · 2024-09-30ProductNeonatal1,713,000USD0001811884-24-000022
    Q3 2024Quarterly · 2024-09-30ProductObstetrics1,053,000USD0001811884-24-000022
    Q2 2024Quarterly · 2024-06-30GeographyDomestic Us5,831,000USD0001811884-24-000018
    Q2 2024Quarterly · 2024-06-30GeographyOutside Us4,569,000USD0001811884-24-000018
    Q2 2024Quarterly · 2024-06-30ProductBlood Pressure Monitoring And Accessories2,383,000USD0001811884-24-000018
    Q2 2024Quarterly · 2024-06-30ProductGynecology Electrosurgery Urology5,452,000USD0001811884-24-000018
    Q2 2024Quarterly · 2024-06-30ProductNeonatal1,546,000USD0001811884-24-000018
    Q2 2024Quarterly · 2024-06-30ProductObstetrics1,019,000USD0001811884-24-000018
    Q1 2024Quarterly · 2024-03-31GeographyDomestic Us6,191,000USD0001811884-24-000015
    Q1 2024Quarterly · 2024-03-31GeographyOutside Us5,149,000USD0001811884-24-000015
    Q1 2024Quarterly · 2024-03-31ProductBlood Pressure Monitoring And Accessories3,212,000USD0001811884-24-000015
    Q1 2024Quarterly · 2024-03-31ProductGynecology Electrosurgery Urology5,461,000USD0001811884-24-000015
    Q1 2024Quarterly · 2024-03-31ProductNeonatal1,642,000USD0001811884-24-000015
    Q1 2024Quarterly · 2024-03-31ProductObstetrics1,025,000USD0001811884-24-000015
    Q3 2023Quarterly · 2023-09-30GeographyDomestic Us7,265,000USD0001811884-23-000021
    Q3 2023Quarterly · 2023-09-30GeographyOutside Us5,240,000USD0001811884-23-000021
    Q3 2023Quarterly · 2023-09-30ProductBlood Pressure Monitoring And Accessories3,826,000USD0001811884-23-000021
    Q3 2023Quarterly · 2023-09-30ProductGynecology Electrosurgery Urology5,372,000USD0001811884-23-000021
    Q3 2023Quarterly · 2023-09-30ProductNeonatal1,884,000USD0001811884-23-000021
    Q3 2023Quarterly · 2023-09-30ProductObstetrics1,423,000USD0001811884-23-000021

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.